ARTICLE | Finance

Ebb & Flow

November 8, 2004 8:00 AM UTC

The acquisition of French neurology and cancer play Synt:em by Sonus (SNUS) led some sector watchers to wonder if U.S. banks are seeking European asset opportunities. They may well be, but in this particular case the companies instigated the deal, according to Tucker Kelly of Adams Harkness, which advised Synt:em on the deal. "The deal was very much company driven," Kelly told Ebb & Flow.

All the same, Kelly noted, "part of our strategy is to look in Europe for companies and assets that can be put together with U.S. companies. There are very good products, technologies and people in Europe that can often be developed faster and better in the U.S." ...